March 1, 2017Current Cardiology Reviews
Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents
Key result
Bioabsorbable polymer-coated drug-eluting stents are being evaluated in clinical trials to potentially improve arterial healing and reduce late ischemic events compared to permanent polymer stents.
Why the study?
Do bioabsorbable polymer-coated drug-eluting stents improve arterial healing and reduce late ischemic events compared to permanent polymer stents?
Comparison
Bioabsorbable polymer-coated drug-eluting stents vs Permanent polymer drug-eluting stents or bare…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Should not change stent selection; leaves open whether bioabsorbable polymers improve healing or reduce events.
Key Points
- This review aims to assess the current state of bioabsorbable polymer-coated drug-eluting stents and their impact on clinical outcomes.
- Review of clinical trials evaluating bioabsorbable polymer-coated drug-eluting stents.
- Examination of the impact of polymer degradation on arterial healing and complications.
- Analysis of the role of drug-eluting stents in reducing restenosis compared to bare metal stents.
- Bioabsorbable stents may improve arterial healing by eliminating chronic inflammation post-drug release.
- Reduced need for long-term dual antiplatelet therapy could lower bleeding risk and healthcare costs.
- Current clinical evaluations show promising results in minimizing late ischemic events.
Structured PICO
Do bioabsorbable polymer-coated drug-eluting stents improve arterial healing and reduce late ischemic events compared to permanent polymer stents?
I
Intervention
Bioabsorbable polymer-coated drug-eluting stents (DES)
C
Comparator
Permanent polymer drug-eluting stents (DES) or bare metal stents (BMS)
Bioabsorbable polymer-coated DES may improve arterial healing and reduce late ischemic events by removing a chronic source of inflammation compared to permanent polymers.
Cite This Study
Hou et al. (2017) reported a review. Bioabsorbable polymer-coated drug-eluting stents vs. Permanent polymer drug-eluting stents was evaluated. Bioabsorbable polymer-coated drug-eluting stents are being evaluated in clinical trials to potentially improve arterial healing and reduce late ischemic events compared to permanent polymer stents.